“Controversial ‘Female Viagra’ Hits the Market, New Questions Arise”

1
75

Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women.  Many are concerned that the drug will be prescribed “off-label,” in populations that the drug was not approved to treat.  This could have serious consequences as taking flibanserin with alcohol, oral contraception, or other medications can significantly increase the risk of side-effects.

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20

1 COMMENT